Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
NASDAQ:IDXX
IDXX Stock Chart & Stats
$636.91
$7.33(1.72%)
At close: 4:00 PM EST
$636.91
$7.33(1.72%)
Day’s Range― - ―
52-Week Range$356.14 - $688.12
Previous CloseN/A
Volume277.29K
Average Volume (3M)413.26K
Market Cap
$50.67B
Enterprise Value$44.51B
Total Cash (Recent Filing)$164.59M
Total Debt (Recent Filing)$1.24B
Price to Earnings (P/E)53.0
Beta1.09
Next Earnings
Nov 03, 2025EPS Estimate
3.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.63
Shares Outstanding80,004,690
10 Day Avg. Volume404,314
30 Day Avg. Volume413,261
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue11.02
Enterprise Value/Gross Profit17.91
Enterprise Value/Ebitda31.75
Forecast
1Y Price Target
$723.89Price Target Upside13.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Customer GrowthNew customer growth has been consistent, building off a high-touch US commercial footprint.
Long-Term Growth StrategyConfidence in the company’s long-term growth strategy despite near-term pressures from clinical visits.
Product DemandThe innovation flywheel continues to churn out in-demand products & services.
Bears Say
Revenue GrowthRevenue growth projections are below consensus, reflecting a conservative outlook amid macro uncertainties.
Vet Visit DeclineUS vet visits have declined every quarter since 2022, posing a pressure point for IDEXX.
Veterinary Visits PressureUS vet visits have declined every quarter since 2022, which pressures revenue growth reliant on visit recovery.
Idexx Laboratories News
IDXX FAQ
What was Idexx Laboratories’s price range in the past 12 months?
Idexx Laboratories lowest stock price was $356.14 and its highest was $688.12 in the past 12 months.
What is Idexx Laboratories’s market cap?
Idexx Laboratories’s market cap is $50.67B.
When is Idexx Laboratories’s upcoming earnings report date?
Idexx Laboratories’s upcoming earnings report date is Nov 03, 2025 which is in 18 days.
How were Idexx Laboratories’s earnings last quarter?
Idexx Laboratories released its earnings results on Aug 04, 2025. The company reported $3.63 earnings per share for the quarter, beating the consensus estimate of $3.302 by $0.328.
Is Idexx Laboratories overvalued?
According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued.
Does Idexx Laboratories pay dividends?
Idexx Laboratories does not currently pay dividends.
What is Idexx Laboratories’s EPS estimate?
Idexx Laboratories’s EPS estimate is 3.14.
How many shares outstanding does Idexx Laboratories have?
Idexx Laboratories has 80,004,690 shares outstanding.
What happened to Idexx Laboratories’s price movement after its last earnings report?
Idexx Laboratories reported an EPS of $3.63 in its last earnings report, beating expectations of $3.302. Following the earnings report the stock price went up 27.494%.
Which hedge fund is a major shareholder of Idexx Laboratories?
Currently, no hedge funds are holding shares in IDXX
Idexx Laboratories Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$723.89 (13.66% Upside)
$723.89 (13.66% Upside)
Blogger Sentiment
Bullish
IDXX Sentiment 77%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 554.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $34.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 8.6%
Last 30 Days ▲ 8.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.24%
12-Months-Change
Fundamentals
Return on Equity
64.87%
Trailing 12-Months
Asset Growth
-2.46%
Trailing 12-Months
Company Description
Idexx Laboratories
IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics, water testing, and dairy and food safety. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX primarily serves the veterinary market with innovative products and services that enhance the health and well-being of pets. The company operates in several segments, including Companion Animal Group, Livestock, Poultry, and Dairy, as well as Water and Food Testing. Its core products include diagnostic tests, instruments, and software solutions that facilitate rapid and accurate disease diagnosis and management.
IDXX Company Deck
IDXX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong quarter for IDEXX with significant revenue and EPS growth, driven by robust international performance and record instrument placements. However, challenges such as a decline in U.S. clinical visits and a dip in Rapid assay revenues were noted. Despite these lowlights, the overall sentiment of the call leans positive due to the outweighing highlights and an optimistic outlook for the remainder of 2025.View all IDXX earnings summariesIDXX Revenue Breakdown
91.70% CAG
4.75% Water
3.13% LPD
0.42% Other
IDXX Stock 12 Month Forecast
Average Price Target
$723.89
▲(13.66% Upside)
Technical Analysis
Ownership Overview
0.28% Insiders
26.95% Mutual Funds
26.91% Other Institutional Investors
15.24% Public Companies and
Individual Investors